# Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

> **NCT01669096** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** GSK Biologicals' investigational TB vaccine GSK 692342

## Key facts

- **NCT ID:** NCT01669096
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-21
- **Primary completion:** 2012-12-06
- **Final completion:** 2013-05-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669096, "Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01669096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*